Anthropic’s Claude 4.7 and OpenAI’s Codex launch back-to-back, boosting AI coding power while quietly increasing token costs ...
Claude is Anthropic’s AI assistant for writing, coding, analysis, and enterprise workflows, with newer tools such as Claude ...
The Rocky Linux ecosystem now has a single, authoritative destination to verify and publish hardware, software and AI infrastructure compatibility with RLC Pro, RLC Pro AI and RLC Pro Hardened, so ...
OpenAI is moving a step deeper into the software development stack with its planned acquisition of Astral, a company known for building widely used open-source Python developer tools. The move is less ...
OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Agent workflows make transport a first-order ...
Feb 25 (Reuters) - Software provider C3.ai (AI.N), opens new tab said it is cutting 26% of its global workforce as part of a restructuring push under new CEO Stephen Ehikian, and also forecast current ...
C3.ai (NYSE:AI) is set to give its latest quarterly earnings report on Wednesday, 2026-02-25. Here's what investors need to know before the announcement. Analysts estimate that C3.ai will report an ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Jan 27 (Reuters) - Enterprise artificial intelligence software provider C3.AI (AI.N), opens new tab is in talks to merge with software company Automation Anywhere, The Information reported on Tuesday, ...
C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis (MPGN) generally result in glomerular C3 deposition and irreversible kidney damage. The efficacy and safety of ...